We are live on ! Find out more
ZYME icon

Zymeworks
ZYME

43 hedge funds and large institutions have $121M invested in Zymeworks in 2018 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

560% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 5

367% more capital invested

Capital invested by funds: $25.9M → $121M (+$94.8M)

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

187% more funds holding

Funds holding: 15 → 43 (+28)

23.32% more ownership

Funds ownership: 8.15% → 31.47% (+23%)

Holders
43
Holders Change
+28
Holders Change %
+186.67%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
6
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BBA
Baker Bros. Advisors
New York
+$20.3M
2
CCM
Camber Capital Management
Massachusetts
+$19.4M
3
FCM
Farallon Capital Management
California
+$11.7M
4
VC
Vivo Capital
California
+$9.61M
5
PA
Perceptive Advisors
New York
+$6.66M

Top Sellers

1
PCM
PenderFund Capital Management
British Columbia, Canada
-$5.36M
2
Franklin Resources
Franklin Resources
California
-$638K
3
SLG
Stanley-Laman Group
Pennsylvania
-$439K
4
Norges Bank
Norges Bank
Norway
-$212K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$23K
Name Holding Trade Value Shares
Change 		Change in
Stake
Stifel Financial
26
Stifel Financial
Missouri
$262K +$275K +17,737 New
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$235K +$30.1K +1,944 +14%
ECM
28
Element Capital Management
New York
$155K +$162K +10,460 New
CSS
29
Cubist Systematic Strategies
Connecticut
$101K +$106K +6,844 New
Morgan Stanley
30
Morgan Stanley
New York
$53K +$55.8K +3,600 New
Bank of Montreal
31
Bank of Montreal
Ontario, Canada
$28K -$1.24K -80 -4%
GWM
32
Geneos Wealth Management
Colorado
$23K +$24.6K +1,588 New
TRCT
33
Tower Research Capital (TRC)
New York
$18K +$14.1K +908 +291%
Barclays
34
Barclays
United Kingdom
$18K +$19.3K +1,248 New
AG
35
Advisor Group
Arizona
$17K +$2.46K +159 +16%
Parallax Volatility Advisers
36
Parallax Volatility Advisers
California
$16K – – –
Bank of America
37
Bank of America
North Carolina
$15K +$15.5K +1,000 New
US Bancorp
38
US Bancorp
Minnesota
$15K +$15.5K +1,000 New
PHK
39
Point72 Hong Kong
Hong Kong
$7K +$7.22K +466 New
TL
40
TrueWealth LLC
Georgia
$3K +$3.36K +217 New
WEC
41
Winslow Evans & Crocker
Massachusetts
$2K +$775 +50 New
HR
42
Howe & Rusling
New York
$1K +$775 +50 New
PCM
43
PenderFund Capital Management
British Columbia, Canada
– -$5.36M -325,058 Closed
SLG
44
Stanley-Laman Group
Pennsylvania
– -$439K -36,556 Closed
Norges Bank
45
Norges Bank
Norway
– -$212K -17,600 Closed
Acadian Asset Management
46
Acadian Asset Management
Massachusetts
– -$23K -1,845 Closed
UBS Group
47
UBS Group
Switzerland
– -$5K -440 Closed
Toronto Dominion Bank
48
Toronto Dominion Bank
Ontario, Canada
– +$325 +21 New
1
2

ZYME Hedge Fund Activity: Q2 2018 in Review

43 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q2 2018, worth a combined $121M — up 367% from $25.9M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new ZYME positions and 5 closed out — a net gain of 28 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $20.3M. The largest seller was PenderFund Capital Management, exiting entirely with an estimated $5.36M sold.

  • 43 institutional investors held Zymeworks (ZYME) as of Q2 2018, up from 15 in Q1 2018.
  • Funds reported $121M of Zymeworks stock for Q2 2018, up 367% quarter-over-quarter.
  • 33 funds opened new Zymeworks positions in Q2 2018 and 5 closed out, a net change of +28 holders.
  • The largest Zymeworks buyer in Q2 2018 was Baker Bros. Advisors, an estimated $20.3M added.
  • The largest Zymeworks seller in Q2 2018 was PenderFund Capital Management, an estimated $5.36M sold.

Based on aggregated 13F filings for Q2 2018.